April 24, 2019
Teva drops clinical development program for use of fremanezumab in episodic cluster headache
Teva is discontinuing the clinical developmentprogram for use of fremanezumab in cluster headaches.
Pharmaceuticals, Biotechnology and Life Sciences
Tag: headache